Евразийские клинические рекомендации по профилактике и лечению сердечно-сосудистых заболеваний у больных с ожирением (2022)

Автор: Чазова И.Е., Жернакова Ю.В., Блинова Н.В., Маркова Т.Н., Мазурина Н.В., Жиров И.В., Ускач Т.М., Сафиуллина А.А., Миронова О.Ю., Елфимова Е.М., Литвин А.Ю., Железнова Е.А., Юричева Ю.А., Азизов В.А., Григоренко Е.А., Рахимов З.Я., Касымова С.Д., Мустафаев И.И., Нарзуллаева А.Р., Полупанов А.Г., Сарыбаев А.Ш., Срожидинова Н.З.

Журнал: Евразийский кардиологический журнал @eurasian-cardiology-journal

Рубрика: Клинические рекомендации

Статья в выпуске: 3, 2022 года.

Бесплатный доступ

Отказ от ответственности. Рекомендации ЕАК отражают точку зрения ЕАК и были подготовлены после тщательного изучения научных и медицинских данных, имеющихся на момент их публикации. ЕАК не несут ответственности в случае какого-либо противоречия, несоответствия и / или неоднозначности между Рекомендациями ЕАК и любыми другими официальными рекомендациями или руководствами, выпущенными соответствующими органами общественного здравоохранения, в частности, в отношении правильного использования медицинских или терапевтических стратегий. Медицинским работникам рекомендуется в полной мере учитывать Рекомендации ЕАК при оценке своего клинического суждения, а также при определении и реализации профилактических, диагностических или терапевтических медицинских стратегий. Тем не менее, Рекомендации ЕАК никоим образом не отменяют индивидуальную ответственность медицинских работников за принятие надлежащих и точных решений с учетом состояния здоровья каждого пациента и в консультации с этим пациентом и, при необходимости и / или необходимости, опекуна пациента. Рекомендации ЕАК не освобождают медицинских работников от полного и тщательного рассмотрения соответствующих официальных обновленных рекомендаций или руководств, выпущенных компетентными органами общественного здравоохранения, для рассмотрения каждого медицинского случая в свете современных научно обоснованных рекомендаций в соответствии с их этическими и профессиональными обязательствами. Кроме того, медицинский работник обязан проверять действующие правила и положения, касающиеся лекарств и медицинских изделий, на момент назначения по рецепту.

Еще

Ожирение, артериальная гипертония, сердечно-сосудистые заболевания, ибс, нарушения ритма, хсн

Короткий адрес: https://sciup.org/143179489

IDR: 143179489   |   DOI: 10.38109/2225-1685-2022-3-6-56

Список литературы Евразийские клинические рекомендации по профилактике и лечению сердечно-сосудистых заболеваний у больных с ожирением (2022)

  • Глобальный план действий по профилактике неинфекционных заболеваний и борьбе с ними на 2013-2020 гг. ВОЗ, Женева, Швейцария; 2013:107с. WHO.URL: http://www.who.int/nmh/events/ncd_action_plan/en/#.
  • Шальнова С.А., Деев А.Д. Масса тела у мужчин и женщин (результаты обследования российской, национальной, представительной выборки населения) Кардиоваскулярная терапия и профилактика. 2008;7(6):60-3.
  • Шальнова С.А., ДеевА.Д., Баланова Ю.А., и др. Двадцатилетние тренды ожирения и артериальной гипертонии и их ассоциации в России. Кардиоваскулярная терапия и профилактика, 2017;16(4):4-10. https://doi.org/10.15829/1728-8800-2017-4-4-10
  • Баланова Ю.А., Шальнова С.А., Деев А.Д., Имаева А.Э., Концевая А.В., Муромцева Г.А., Капустина А.В., Евстифеева С.Е., Драпкина О.В. Ожирение в российской популяции - распространенность и ассоциации с факторами риска хронических неинфекционных заболеваний. Российский кардиологический журнал. 2018;(6):123-130. https://doi.org/10.15829/1560-4071-2018-6-123-130
  • Misra A, Jayawardena R, Anoop S. Obesity in South Asia: Phenotype, Morbidities, and Mitigation. Curr Obes Rep. 2019;8(1):43-52. https://doi.org/10.1007/s13679-019-0328-0
  • Cheng L, Yan W, Zhu L, et al. Comparative analysis of IDF, ATPIII and CDS in the diagnosis of metabolic syndrome among adult inhabitants in Jiangxi Province, China. PLoS One. 2017;12(12):e0189046. https://doi.org/10.1371/journal.pone.0189046
  • Nishida C, Barba C, Cavalli-Sforza T, et al. Appropriate bodymass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157-163. https://doi.org/10.1016/S0140-6736(03)15268-3
  • Pan W-H, Yeh W-T. How to define obesity? Evidence-based multiple action points for public awareness, screening, and treatment: an extension of Asian-Pacific recommendations. Asia Pac J Clin Nutr. 2008. https://doi.org/10.6133/apjcn.2008.17.3.02
  • Nam GE, Park HS. Perspective on Diagnostic Criteria for Obesity and Abdominal Obesity in Korean Adults. J Obes Metab Syndr. 2018;27(3):134-142. https://doi.org/10.7570/jomes.2018.27.3.134
  • Zeng Q, He Y, Dong S, et al. Optimal cut-off values of BMI, waist circumference and waist:height ratio for defining obesity in Chinese adults. Br J Nutr. 2014;112(10):1735-1744. https://doi.org/10.1017/S0007114514002657
  • Jih J, Mukherjea A, Vittinghoff E, et al. Using appropriate body mass index cut points for overweight and obesity among Asian Americans. Prev Med (Baltim). 2014;65:1-6. https://doi.org/10.1016/j.ypmed.2014.04.010
  • Simonnet A, Chetboun M, Poissy J, et al. High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation. Obesity (Silver Spring). 2020 Jul; 28(7):1195-1199. https://doi.org/10.1002/oby.22831
  • Ekelund, U et al. Physical activity and all-cause mortality across levels of overall and abdominal adiposity in European men and women: the European Prospective Investigation into Cancer and Nutrition Study (EPIC) American Journal of Clinical Nutrition. Am J Clin Nutr. 2015 Mar; 101(3):613-621. https://doi.org/10.3945/ajcn.114.100065
  • Blüher M. O. Metabolically Healthy Obesity. Endocrine Reviews, June 2020; 41(3):1-16. https://doi.org/10.1210/endrev/bnaa004
  • Caleyachetty R, Thomas GN, Toulis KA, et al. Metabolically healthy obese and incident cardiovascular disease events among 3.5 million men and women. J Am Coll Cardiol. 2017;70(12):1429-1437. https://doi.org/10.1016/j.jacc.2017.07.763
  • Fan J, Song Y, Chen Y, Hui R, Zhang W. Combined effect of obesity and cardio-metabolic abnormality on the risk of cardiovascular disease: a metaanalysis of prospective cohort studies. Int J Cardiol. 2013;168(5):4761-4768. https://doi.org/10.1016/j.ijcard.2013.07.230
  • Zheng R, Zhou D, Zhu Y. The long-term prognosis of cardiovascular disease and all-cause mortality for metabolically healthy obesity: a systematic review and meta-analysis. J Epidemiol Community Health. 2016;70(10):1024-1031. https://doi.org/10.1136/jech-2015-206948
  • Moussa O, Arhi C, Ziprin P, Darzi A, Khan O, Purkayastha S. Fate of the metabolically healthy obese-is this term a misnomer? A study from the Clinical Practice Research Datalink. Int J Obes (Lond). 2019;43(5):1093-1101. https://doi.org/10.1038/s41366-018-0096-z
  • Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis. Ann Intern Med. 2013;159(11):758-769. https://doi.org/10.7326/0003-4819-159-11-201312030-00008
  • Frank L.J. Visseren, Francois Mach, Yvo M. Smulders, David Carballo, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal. 2021;42:3227-3337. https://doi.org/10.1093/eurheartj/ehab484
  • Lauer MS, Anderson KM, Kannel WB, Levy D. The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA 1991;266:231-236. PMID:1829117
  • Lambert E, Sari CI, Dawood T, Nguyen J, McGrane M, Eikelis N, Chopra R, Wong C, Chatzivlastou K, Head G, Straznicky N, Esler M, Schlaich M, Lambert G. Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults.Hypertension. 2010;56:351-358. https://doi.org/10.1161/hypertensionaha.110.155663
  • Железнова Е.А., Жернакова Ю.В., Погорелова О.А. и др. Состояние сосудистой стенки и его связь с периваскулярной жировой тканью и другими жировыми депо у пациентов молодого возраста с абдоминальным ожирением. Системные гипертензии. 2019;16(4):80-86https://syst-hypertension.ru/2075-082X/article/view/33559
  • Bell JA, Hamer M, Sabia S, Singh-Manoux A, Batty GD, Kivimaki M. The natural course of healthy obesity over 20 years. J Am Coll Cardiol 2015;65:101-102. https://doi.org/10.1016/j.jacc.2014.09.077
  • Чазова И.Е., Жернакова Ю.В. от имени экспертов. Клинические рекомендации. Диагностика и лечение артериальной гипертонии. Системные гипертензии 2019;16(1):6-31. https://doi.org/10.26442/2075082X.2019.1.190179
  • SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J 2021;42:2439-2454. https://doi.org/10.1093/eurheartj/ehab309
  • SCORE2-OP working group and ESC Cardiovascular risk collaboration. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. Eur Heart J 2021;42:2455-2467. https://doi.org/10.1093/eurheartj/ehab312
  • Ожирение у взрослых. Клинические рекомендации Минздрава России, 2020.
  • World Health Organization. Obesity: preventing and managing the global epidemic. 1997, Geneva: WHO.
  • Prospective Studies Collaboration, Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, Qizilbash N, Collins R, Peto R. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009 Mar 28;373(9669):1083-96. https://doi.org/10.1016/S0140-6736(09)60318-4. Epub 2009 Mar 18. PMID:19299006;PMCID: PMC2662372.
  • Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res. 1998 Sep;6 Suppl 2:51S-209S. Erratum in: Obes Res 1998 Nov;6(6):464. PMID:9813653.
  • Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:I-XII, 1-253. PMID:11234459.
  • Garvey WT, Garber AJ, Mechanick JI, et al. American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease. Endocr Pract. 2014;20(9):977-989. https://doi.org/10.4158/ep14280.ps
  • Tsai AG, Wadden TA. In the clinic: obesity. Ann Intern Med. 2013 Sep 3;159(5):ITC3-1-ITC3-15; quiz ITC3-16. https://doi.org/10.7326/0003-4819-159-5-201309030-01003. PMID:24026335.
  • Willett WC, Dietz WH, Colditz GA. Guidelines for healthy weight. N Engl J Med 1999; 341:427. https://doi.org/10.1056/nejm199908053410607
  • Ogden CL, Carroll MD, Lawman HG, et al. Trends in Obesity Prevalence Among Children and Adolescents in the United States, 1988-1994 Through 2013-2014. JAMA 2016; 315:2292. https://doi.org/10.1001/jama.2016.6361
  • Van Pelt RE, Gavin KM, Kohrt WM. Regulation of Body Composition and Bioenergetics by Estrogens. Endocrinol Metab Clin North Am 2015;44:663. https://doi.org/10.1016/j.ecl.2015.05.011
  • Kohrt WM, Wierman ME. Preventing Fat Gain by Blocking Follicle-Stimulating Hormone. N Engl J Med 2017;377:293. https://doi.org/10.1056/nejmcibr1704542
  • Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of WHO/IDF Consultation. 2006
  • Pearce E. Thyroid hormone and obesity. Curr Opin Endocrinol Diabetes Obes. 2012;19:408-13. https://doi.org/10.1097/med.0b013e328355cd6c
  • Daniel E, Newell-Price J. Cushing’s syndrome. Medicine. 2017;45(8):475-9.
  • Biondi B. Thyroid and obesity: an intriguing relationship. J Clin Endocrin Metab. 2010;95:3614-7. https://doi.org/10.1210/jc.2010-1245
  • Rotondi M, Magri F, Chiovato L. Thyroid and obesity: not a one-way interaction. J Clin Endocrin Metab. 2011;96:344-6. https://doi.org/10.1210/jc.2010-2515
  • Laurberg P, Knudsen N, Andersen S, et al. Thyroid function and obesity. Eur Thyroid J. 2012;1:159-67. https://doi.org/10.1159/000342994
  • Duntas L, Biondi B. The interconnections between obesity, thyroid function, and autoimmunity: the multifold role of leptin. Thyroid. 2013;23:646-53. https://doi.org/10.1089/thy.2011.0499
  • Boscaro M, Arnaldi G. Approach to the patient with possible Cushing’s syndrome. J Clin Endocrinol Metab. 2009;94(9):3121-31. https://doi.org/10.1210/jc.2009-0612
  • Auriemma R. The effects of hyperprolactinemia and its control on metabolic diseases. Expert Rev Endocrinol Metab. 2018;13(2):99-106. https://doi.org/10.1080/17446651.2018.1434412
  • Dos Santos Silva CM, Barbosa FR, Lima GA, et al. BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists. Obesity. 2011;19:800-5. https://doi.org/10.1038/oby.2010.150
  • Lohman, T.G., Roche, A.F. and Martorell, R. (1988) Anthropometric standardization reference manual. Human Kinetics Books, Chicago.
  • Ford ES, Mokdad AH, Giles WH. Trends in waist circumference among U.S. adults. Obes Res. 2003 Oct;11(10):1223-31. https://doi.org/10.1038/oby.2003.168. PMID:14569048.
  • Romero-Corral A, Somers VK, Sierra-Johnson J, Thomas RJ, Collazo-Clavell ML, Korinek J, Allison TG, Batsis JA, Sert-Kuniyoshi FH, Lopez-Jimenez F. Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond). 2008;32:959-966. https://doi.org/10.1038/ijo.2008.11
  • Pack QR, Rodriguez-Escudero JP, Thomas RJ, Squires RW, Johnson L, Somers VK, Lopez-Jimenez F. Diagnostic performance of weight loss to predict body fatness improvement in cardiac rehabilitation patients. J Cardiopulm Rehabil Prev. 2013;33:68-76. https://doi.org/10.1097/HCR.0b013e31827fe7e3
  • Okorodudu DO, Jumean MF, Montori VM, Romero-Corral A, Somers VK, Erwin PJ, Lopez-Jimenez F. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes (Lond). 2010;34:791-799. https://doi.org/10.1038/ijo.2010.5
  • Heymsfield SB, Peterson CM, Thomas DM, Heo M, Schuna JM Why are there race/ethnic differences in adult body mass index-adiposity relationships? A quantitative critical review. Obes Rev. 2016;17:262-275. https://doi.org/10.1111/obr.12358
  • Rao G, Powell-Wiley TM, Ancheta I, Hairston K, Kirley K, Lear SA, North KE, Palaniappan L, Rosal MC; on behalf of the American Heart Association Obesity Committee of the Council on Lifestyle and Cardiometabolic Health. Identification of obesity and cardiovascular risk in ethnically and racially diverse populations: a scientific statement from the American Heart Association [published correction appears in Circulation. 2015;132:e130]. Circulation. 2015;132:457-472. https://doi.org/10.1161/CIR.0000000000000223
  • Чазова И.Е. Рекомендации по ведению больных артериальной гипертонией с метаболическими нарушениями / И.Е. Чазова, Недогода С.В., Жернакова Ю.В. и др. Кардиологический вестник. 2014;1:3-57.
  • Дедов И.И., Шестакова М.В., Мельниченко Г.А., Мазурина Н.В., Андреева Е.Н. и соавт. Междисциплинарные клинические рекомендации «Лечение ожирения и коморбидных заболеваний» Ожирение и метаболизм. 2021;18(1):5-99. https://doi.org/10.14341/omet12714
  • Kim H, Caulfield LE, Rebholz CM. Healthy Plant-Based Diets Are Associated with Lower Risk of All-Cause Mortality in US Adults. J Nutr. 2018;148(4):624-631. https://doi.org/10.1093/jn/nxy019
  • Satija A, Bhupathiraju SN, Spiegelman D, et al. Healthful and Unhealthful Plant-Based Diets and the Risk of Coronary Heart Disease in U.S. Adults. J Am Coll Cardiol. 2017;70(4):411-422. https://doi.org/10.1016/j.jacc.2017.05.047
  • Sotos-Prieto M, Bhupathiraju SN, Mattei J, et al. Association of Changes in Diet Quality with Total and Cause Specific Mortality. N Engl J Med. 2017;377(2):143-153. https://doi.org/10.1056/NEJMoa1613502
  • Alberti K.G. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation / K.G. Alberti, P.Z. Zimmet // Diabet Med. 1998;15:539.
  • Silver HJ, Welch EB, Avison MJ, Niswender KD: Imaging body composition in obesity and weight loss: challenges and opportunities. Diabetes Metab Syndr Obes 2010;3:337-347. https://doi.org/10.2147/dmsott.s9454
  • Bolanowski M, Nilsson BE: Assessment of human body composition using dual-energy x-ray absorptiometry and bioelectrical impedance analysis. Med Sci Monit 2001;7:1029-1033. PMID:11535954
  • Cornier M-A, Després J-P, Davis N, Grossniklaus DA, Klein S, Lamarche B, Lopez-Jimenez F, Rao G, St-Onge M-P,Towfighi A, Poirier P; on behalf of the American Heart Association Obesity Committee of the Council on Nutrition, Physical Activity and Metabolism, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular Radiology and Intervention,Council on Cardiovascular Nursing, Council on Epidemiology and Prevention, Council on the Kidney in Cardiovascular Disease, and Stroke Council: Assessing adiposity: a scientific statement from the American Heart Association. Circulation 2011;124:1996-2019. https://doi.org/10.1161/CIR.0b013e318233bc6a
  • Yumuk V, Tsigos C, Fried M, Schindler K, Busetto L, Micic D, Toplak H; Obesity Management Task Force of the European Association for the Study of Obesity. European Guidelines for Obesity Management in Adults. Obes Facts. 2015;8(6):402-24. https://doi.org/10.1159/000442721. Epub 2015 Dec 5. Erratum in: Obes Facts. 2016;9(1):64. PMID:26641646;PMCID: PMC5644856.
  • LaForgia, J., Dollman, J., Dale, M.J., Withers, R.T. and Hill, A.M. (2009), Validation of DXA Body Composition Estimates in Obese Men and Women. Obesity, 17: 821-826. https://doi.org/10.1038/oby.2008.595
  • Adult Obesity Algorithm eBook: Detailed overview of Obesity Medicine Bays HE, McCarthy W, Burridge K, Tondt J, Karjoo S, Christensen S, Ng J, Golden A, Davisson L, Richardson L. Obesity Algorithm eBook, presented by the Obesity Medicine Association. 2021; https://obesitymedicine.org/obesity-algorithm (Accessed = Insert date)
  • Aragon, A.A., Schoenfeld, B.J., Wildman, R. et al. International society of sports nutrition position stand: diets and body composition. J Int Soc Sports Nutr. 14,16(2017). https://doi.org/10.1186/s12970-017-0174-y
  • Völgyi E, Tylavsky FA, Lyytikäinen A, Suominen H, Alén M, Cheng S. Assessing body composition with DXA and bioimpedance: effects of obesity, physical activity, and age. Obesity (Silver Spring). 2008 Mar;16(3):700-5. https://doi.org/10.1038/oby.2007.94. Epub 2008 Jan 17. PMID:18239555.
  • Fakhrawi DH, Beeson L, Libanati C, Feleke D, Kim H, Quansah A, Darnell A, Lammi-Keefe CJ, Cordero-MacIntyre Z. Comparison of body composition by bioelectrical impedance and dual-energy x-ray absorptiometry in overweight/obese postmenopausal women. J Clin Density. 2009 Apr-Jun; 12(2):238-44. https://doi.org/10.1016/j.jocd.2009.01.004. Epub 2009 Mar 13. PMID:19285894.
  • Bray GA, DeLany JP, Volaufova J, Harsha DW, Champagne C. Prediction of body fat in 12-y-old African American and white children: evaluation of methods. Am J Clin Nutr. 2002 Nov;76(5):980-90. https://doi.org/10.1093/ajcn/76.5.980. PMID:12399269.
  • Hankinson SJ, Williams CH, Ton VK, Gottlieb SS, Hong CC. Should we overcome the resistance to bioelectrical impedance in heart failure? Expert Rev Med Devices. 2020 Aug;17(8):785-794. https://doi.org/10.1080/17434440.2020.1791701. Epub 2020 Jul 13. PMID:32658589;PMCID: PMC8356137.
  • Powell-Wiley TM, Poirier P, Burke LE, Després JP, Gordon-Larsen P, Lavie CJ, Lear SA, Ndumele CE, Neeland IJ, Sanders P, St-Onge MP; American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Epidemiology and Prevention; and Stroke Council. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021 May 25;143(21):e984-e1010. https://doi.org/10.1161/CIR.0000000000000973. PMID:33882682;PMCID: PMC8493650.
  • Neeland IJ, Poirier P, Després JP. Cardiovascular and metabolic heterogeneity of obesity: clinical challenges and implications for management.Circulation. 2018;137:1391-1406. https://doi.org/10.1161/CIRCULATIONAHA.117.029617
  • Sjöström L. A computer-tomography based multicompartment body composition technique and anthropometric predictions of lean body mass, total and subcutaneous adipose tissue. Int J Obes. 1991 Sep;15 Suppl 2:19-30. PMID:1794934.
  • Shah RV, Anderson A, Ding JZ, Budoff M, Rider O, Petersen SE, Jensen MK, Koch M, Allison M, Kawel-Boehm N, et al.. Pericardial, but not hepatic, fat by CT Is Associated With cv outcomes and structure: the Multi-Ethnic Study of Atherosclerosis.JACC Cardiovasc Imag. 2017;10:1016-1027. https://doi.org/10.1016/j.jcmg.2016.10.024
  • Hruskova J, Maugeri A, Podrouzkova H, Stipalova T, Jakubik J, Barchitta M, Medina-Inojosa JR, Homolka M, Agodi A, Kunzova S, et al.. Association of cardiovascular health with epicardial adipose tissue and intima media thickness: the Kardiovize study.J Clin Med. 2018; 7:113. https://doi.org/10.3390/jcm7050113
  • Iacobellis G, Ribaudo MC, Assael F, Vecci E, Tiberti C, Zappaterreno A, Di Mario U, Leonetti F. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk.J Clin Endocrinol Metab. 2003; 88:5163-5168. https://doi.org/10.1210/jc.2003-030698
  • Mahabadi AA, Massaro JM, Rosito GA, Levy D, Murabito JM, Wolf PA, O’Donnell CJ, Fox CS, Hoffmann U. Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study.Eur Heart J. 2009; 30:850-856. https://doi.org/10.1093/eurheartj/ehn573
  • Ong KL, Ding J, McClelland RL, Cheung BM, Criqui MH, Barter PJ, Rye KA, Allison MA. Relationship of pericardial fat with lipoprotein distribution: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2015;241:664-670. https://doi.org/10.1016/j.atherosclerosis.2015.06.027
  • Elming MB, Lønborg J, Rasmussen T, Kühl JT, Engstrøm T, Vejlstrup N, Køber L, Kofoed KF. Measurements of pericardial adipose tissue using contrast enhanced cardiac multidetector computed tomography-comparison with cardiac magnetic resonance imaging. Int J Cardiovasc Imaging. 2013 Aug;29(6):1401-7. https://doi.org/10.1007/s10554-013-0218-6. PMID:23702948.
  • Sofi F, Abbate R, Gensini GF, Casini A. Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr 2010;92:1189-1196. https://doi.org/10.3945/ajcn.2010.29673
  • Estruch R, Ros E, Salas-Salvado J, Covas MI, Corella D, Aros F, Gomez-Gracia E, Ruiz-Gutierrez V, Fiol M, Lapetra J, Lamuela-Raventos RM, Serra-Majem L, Pinto X, Basora J, Munoz MA, Sorli JV, Martinez JA, Fito M, Gea A, Hernan MA, Martinez-Gonzalez MA, PREDIMED Study Investigators. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. N Engl J Med 2018;378:e34. https://doi.org/10.1056/nejmoa1800389
  • Brader L, Uusitupa M, Dragsted LO, Hermansen K. Effects of an isocaloric healthy Nordic diet on ambulatory blood pressure in metabolic syndrome: a randomized SYSDIET sub-study. Eur J Clin Nutr 2014;68(1):57-63. https://doi.org/10.1038/ejcn.2013.192
  • Mykkänen OT, Huotari A, Herzig KH et al. Wild blueberries (Vaccinium myrtillus) alleviate inflammation and hypertension associated with developing obesity in mice fed with a high-fat diet. PLoS One 2014;9(12):114790. https://doi.org/10.1371/journal.pone.0114790
  • Erlund I, Koli R, Alfthan G et al. Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol. Am J Clin Nutr 2008; 87(2):323-31. https://doi.org/10.1093/ajcn/87.2.323
  • Yokoyama Y, Nishimura K, Barnard ND et al. Vegetarian diets and blood pressure: a meta-analysis. JAMA Intern Med 2014;174(4):577-87. https://doi.org/10.1001/jamainternmed.2013.14547
  • Appel LJ, Moore TJ, Obarzanek E et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997; 336(16):1117-24. https://doi.org/10.1056/nejm199704173361601
  • Pimenta E, Gaddam KK, Oparil S et al. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension 2009; 54 (3): 475-81. https://doi.org/10.1161/HYPERTENSIONAHA.109.131235
  • Appel LJ, Espeland MA, Easter L et al. Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE). Arch Intern Med 2001;161(5):685-93. https://doi.org/10.1001/archinte.161.5.685
  • Cook NR, Cutler JA, Obarzanek E et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 2007;334(7599):885-8. https://doi.org/10.1136/bmj.39147.604896.55
  • Chang HY, Hu YW, Yue CS et al. Effect of potassium-enriched salt on cardiovascular mortality and medical expenses of elderly men. Am J Clin Nutr 2006;83(6):1289-96. https://doi.org/10.1093/ajcn/83.6.1289
  • He FJ, MacGregor GA. Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials. Lancet 2011;378(9789):380-2. https://doi.org/10.1016/S0140-6736(11)61174-4
  • Strazzullo P, D'Elia L, Kandala NB, Cappuccio FP. Salt intake, stroke, and cardiovascular disease: metaanalysis of prospective studies. BMJ 2009;339:b4567. https://doi.org/10.1136/bmj.b4567
  • Frohlich ED. The salt conundrum: a hypothesis. Hypertension. 2007;50(1):161-6. https://doi.org/10.1161/hypertensionaha.107.088328
  • Streppel MT, Arends LR, van't Veer P et al. Dietary fiber and blood pressure: a meta-analysis of randomized placebo-controlled trials. Arch Intern Med 2005;165(2):150-6. https://doi.org/10.1001/archinte.165.2.150
  • Whelton SP, Hyre AD, Pedersen B et al. Effect of dietary fiber intake on blood pressure: a meta-analysis of randomized, controlled clinical trials. J Hypertens 2005;23(3):475-81. https://doi.org/10.1097/01.hjh.0000160199.51158.cf
  • Vernay M, Aïdara M, Salanave B et al. Diet and blood pressure in 18-74-year-old adults: the French Nutrition and Health Survey (ENNS, 2006-2007). J Hypertens 2012;30(10):1920-7. https://doi.org/10.1097/hjh.0b013e328356c59f
  • Gopinath B, Flood VM, Rochtchina E et al. Influence of high glycemic index and glycemic load diets on blood pressure during adolescence. Hypertension 2012;59(6):1272-7. https://doi.org/10.1161/HYPERTENSIONAHA.112.190991
  • Oude Griep LM, Stamler J, Chan Q, Van Horn L, Steffen LM, Miura K, Ueshima H, Okuda N, Zhao L, Daviglus ML, Elliott P; INTERMAP Research Group. Am J Clin Nutr. 2013 May;97(5):1083-91. https://doi.org/10.3945/ajcn.112.046300
  • Hartley L, May MD, Loveman E et al. Dietary fibre for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2016;1:CD011472. https://doi.org/10.1002/14651858.CD011472.pub
  • Bozzetto L, Costabile G, Della Pepa G et al. Dietary Fibre as a Unifying Remedy for the Whole Spectrum of Obesity-Associated Cardiovascular Risk. Nutrients 2018;10(7):pii:E943. https://doi.org/10.3390/nu10070943
  • Smith CF, Williamson DA, Bray GA, Ryan DH. Flexible vs. Rigid dieting strategies: relationship with adverse behavioral outcomes. Appetite 1999; 32(3):295-305. https://doi.org/10.1006/appe.1998.0204
  • Stewart TM, Williamson DA, White MA. Rigid vs. flexible dieting: association with eating disorder symptoms in nonobese women. Appetite 2002;38(1):39-44. https://doi.org/10.1006/appe.2001.0445
  • Timko CA, Perone J. Rigid and flexible control of eating behavior in a college population. Eating behaviors 2005;6(2):119-25. https://doi.org/10.1016/j.eatbeh.2004.09.002
  • Westenhoefer J, Stunkard AJ, Pudel V. Validation of the flexible and rigid control dimensions of dietary restraint. Int J Eat Disord 1999;26(1):53-64. https://doi.org/10.1002/(sici)1098-108x(199907)26:1%3C53::aid-eat7%3E3.0.co;2-n
  • Davoodi SH, Ajami M, Ayatollahi SA et al. Calorie Shifting Diet Versus Calorie Restriction Diet: A Comparative Clinical Trial Study. Int J Prev Med 2014;5(4):447-56. PMID:24829732PMCID: PMC4018593
  • Adamsson V, Reumark A, Fredriksson I-B et al. Effects of a healthy Nordic diet on cardiovascular risk factors in hypercholesterolemic subjects: a randomized controlled trial [NORDIET]. J Intern Med 2011; 269: 150-9.
  • Eilat-Adar S, Sinai T, Yosefy C, Henkin Y. Nutritional recommendations for cardiovascular disease prevention. Nutrients 2013;5:36463683. https://doi.org/10.3390/nu5093646
  • European Heart Network. Transforming European food and drink policies for cardiovascular health. http://www.ehnheart.org/publications-and-papers/publications/1093:transforming-european-food-and-drinks-policies-for-cardiovascular-health.html (21 July 2020).
  • Mensink RP. Effects of saturated fatty acids on serum lipids and lipoproteins: a systematic review and regression analysis https://apps.who.int/iris/bitstream/handle/10665/246104/9789241565349-eng.pdf?sequence=1 (21 July 2020).
  • Guasch-Ferre M, Satija A, Blondin SA, Janiszewski M, Emlen E, O’Connor LE, Campbell WW, Hu FB, Willett WC, Stampfer MJ. Meta-Analysis of Randomized Controlled Trials of Red Meat Consumption in Comparison With Various Comparison Diets on Cardiovascular Risk Factors. Circulation 2019;139:1828-1845. https://doi.org/10.1161/circulationaha.118.035225
  • He FJ, Tan M, Ma Y, MacGregor GA. Salt Reduction to Prevent Hypertension and Cardiovascular Disease: JACC State-of-the-Art Review. J Am Coll Cardiol 2020;75:632-647. https://doi.org/10.1016/j.jacc.2019.11.055
  • Willett W, Rockstrom J, Loken B, Springmann M, Lang T, Vermeulen S, Garnett T, Tilman D, et al. Food in the Anthropocene: the EAT-Lancet Commission on healthy diets from sustainable food systems. Lancet 2019;393:447-492. https://doi.org/10.1016/s0140-6736(18)31788-4
  • Guasch-Ferre M, Satija A, Blondin SA, Janiszewski M, Emlen E, O’Connor LE, Campbell WW, Hu FB, Willett WC, Stampfer MJ. Meta-Analysis of Randomized Controlled Trials of Red Meat Consumption in Comparison With Various Comparison Diets on Cardiovascular Risk Factors. Circulation 2019;139:1828-1845. https://doi.org/10.1161/circulationaha.118.035225
  • Zeraatkar D, Johnston BC, Bartoszko J, Cheung K, Bala MM, Valli C, Rabassa M, Sit D, Milio K, Sadeghirad B, Agarwal A, Zea AM, Lee Y, Han MA, Vernooij RWM, Alonso-Coello P, Guyatt GH, El Dib R. Effect of Lower Versus Higher Red Meat Intake on Cardiometabolic and Cancer Outcomes: A Systematic Review of Randomized Trials. Ann Intern Med 2019;171:721-731. https://doi.org/10.7326/m19-0622
  • Zheng J, Huang T, Yu Y, Hu X, Yang B, Li D. Fish consumption and CHD mortality: an updated meta-analysis of seventeen cohort studies. Public Health Nutr 2012;15:725-737. https://doi.org/10.1017/s1368980011002254
  • Mullee A, Romaguera D, Pearson-Stuttard J, Viallon V, Stepien M, Freisling H, et al. Association Between Soft Drink Consumption and Mortality in 10 European Countries. JAMA Intern Med 2019;179:1479-1490. https://doi.org/10.1001/jamainternmed.2019.2478
  • World Health Organization. Guideline: sugars intake for adults and children. https://www.who.int/publications/i/item/9789241549028 (21 July 2020)
  • Howell S, Kones R. "Calories in, calories out" and macronutrient intake: the hope, hype, and science of calories. Am J Physiol Endocrinol Metab 2017;313:E608-E612. https://doi.org/10.1152/ajpendo.00156.2017
  • Tobias DK, Chen M, Manson JE, Ludwig DS, Willett W, Hu FB. Effect of low-fat diet interventions versus other diet interventions on long-term weight change in adults: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 2015;3:968-979. https://doi.org/10.1016/S2213-8587(15)00367-8
  • Zomer E, Gurusamy K, Leach R, Trimmer C, Lobstein T, Morris S, James WP, Finer N. Interventions that cause weight loss and the impact on cardiovascular risk factors: a systematic review and meta-analysis. Obes Rev 2016;17:1001-1011. https://doi.org/10.1111/obr.12433
  • Wing RR, Espeland MA, Clark JM, Hazuda HP, Knowler WC, Pownall HJ, Unick J, Wadden T, Wagenknecht L, Action for Health in Diabetes (Look AHEAD) Study Group. Association of Weight Loss Maintenance and Weight Regain on 4-Year Changes in CVD Risk Factors: the Action for Health in Diabetes (Look AHEAD) Clinical Trial. Diabetes Care 2016;39:1345-1355. https://doi.org/10.2337/dc16-0509
  • Doukky R, Mangla A, Ibrahim Z, et al. Impact of Physical Inactivity on Mortality in Patients With Heart Failure. Am J Cardiol. 2016;117(7):1135-1143. https://doi.org/10.1016/j.amjcard.2015.12.060
  • Liu Y, Lee DC, Li Y, Zhu W, Zhang R, Sui X, Lavie CJ, Blair SN. Associations of Resistance Exercise with Cardiovascular Disease Morbidity and Mortality. Med Sci Sports Exerc 2019;51:499-508. https://doi.org/10.1249/mss.0000000000001822
  • Saeidifard F, Medina-Inojosa JR, West CP, Olson TP, Somers VK, Bonikowske AR, Prokop LJ, Vinciguerra M, Lopez-Jimenez F. The association of resistance training with mortality: A systematic review and meta-analysis. Eur J Prev Cardiol 2019;26:1647-1665. https://doi.org/10.1177/2047487319850718
  • Ortega FB, Silventoinen K, Tynelius P, Rasmussen F. Muscular strength in male adolescents and premature death: cohort study of one million participants. BMJ 2012;345:e7279. https://doi.org/10.1136/bmj.e7279
  • Volaklis KA, Halle M, Meisinger C. Muscular strength as a strong predictor of mortality: A narrative review. Eur J Intern Med 2015;26:303-310. https://doi.org/10.1016/j.ejim.2015.04.013
  • Pelliccia A, Sharma S, Gati S, Back M, Borjesson M, Caselli S, Collet JP, Corrado D, Drezner JA, Halle M, Hansen D, Heidbuchel H, Myers J, Niebauer J, Papadakis M, Piepoli MF, Prescott E, Roos-Hesselink JW, Graham Stuart A, Taylor RS, Thompson PD, Tiberi M, Vanhees L, Wilhelm M, ESC Scientific Document Group. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J 2021;42:1796. https://doi.org/10.1093/eurheartj/ehaa605
  • Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM, Nieman DC, Swain DP, American College of Sports Medicine. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc 2011;43:1334-1359. https://doi.org/10.1249/mss.0b013e318213fefb
  • Kraus WE, Powell KE, Haskell WL, Janz KF, Campbell WW, Jakicic JM, Troiano RP, Sprow K, Torres A, Piercy KL, 2018 Physical Activity Guidelines Advisory Committee. Physical Activity, All-Cause and Cardiovascular Mortality, and Cardiovascular Disease. Med Sci Sports Exerc 2019;51:1270-1281. https://doi.org/10.1249/mss.0000000000001939
  • Powell KE, King AC, Buchner DM, Campbell WW, DiPietro L, Erickson KI, Hillman CH, Jakicic JM, Janz KF, Katzmarzyk PT, Kraus WE, Macko RF, Marquez DX, McTiernan A, Pate RR, Pescatello LS, Whitt-Glover MC. The Scientific Foundation for the Physical Activity Guidelines for Americans, 2nd Edition. J Phys Act Health 2018:111. https://doi.org/10.1123/jpah.2018-0618
  • Sattelmair J, Pertman J, Ding EL, Kohl HW, 3rd, Haskell W, Lee IM. Dose response between physical activity and risk of coronary heart disease: a meta-analysis. Circulation 2011;124:789-795. https://doi.org/10.1161/circulationaha.110.010710
  • Hupin D, Roche F, Gremeaux V, Chatard JC, Oriol M, Gaspoz JM, Barthelemy JC, Edouard P. Even a low-dose of moderate-to-vigorous physical activity reduces mortality by 22% in adults aged >/=60 years: a systematic review and meta-analysis. Br J Sports Med 2015;49:1262-1267. https://doi.org/10.1136/bjsports-2014-094306
  • Cradock KA, OL G, Finucane FM, Gainforth HL, Quinlan LR, Ginis KA. Behaviour change techniques targeting both diet and physical activity in type 2 diabetes: A systematic review and meta-analysis. Int J Behav Nutr Phys Act 2017;14:18. https://doi.org/10.1186/s12966-016-0436-0
  • Brickwood KJ, Watson G, O’Brien J, Williams AD. Consumer-Based Wearable Activity Trackers Increase Physical Activity Participation: Systematic Review and Meta-Analysis. JMIR Mhealth Uhealth 2019;7:e11819. https://doi.org/10.2196/11819
  • Torgeson J.S., Hauptman J. XENical in the prevention of diabetes in obese subjects subjects (XENDOS) study. Diabetes Care. 2004;27:155-161. https://doi.org/10.2337/diacare.27.1.155
  • Rossner S., Sjostrom L., Noack R. et al. Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group.Obes. Res. 2000;8(1): 49-61. https://doi.org/10.1038/oby.2000.8
  • Pi-Sunyer X, Astrup A, Fujioka K, et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med.2015;373(1):11-22. https://doi.org/10.1056/NEJMoa1411892
  • le Roux CW, Astrup A, Fujioka K, et al. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomized, double-blind trial. Lancet. 2017;389(10077):1399-1409. https://doi.org/10.1016/s0140-6736(17)30069-7
  • Blackman A, Foster GD, Zammit G, et al. Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial. Int J Obes (Lond). 2016;40(8):1310-1319. https://doi.org/10.1038/ij o.2016.52
  • Wadden TA, Hollander P, Klein S et al. Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study. International Journal of Obesity. 2013;37:1443-1451; https://doi.org/10.1038/ijo.2013.120
  • Marso SP, Daniels GH, Brown-Frandsen K, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375(4):311-22. https://doi.org/10.1056/NEJMoa1603827
  • TA Wadden, P Hollander, S Klein et al. Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study. International Journal of Obesity. 2013;37:1443-1451; https://doi.org/10.1038/ijo.2013.120
  • legal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a sys- tematic review and meta-analysis. JAMA 2013;309:71-82. https://doi.org/10.1001/jama.2012.113905
  • Global BMI Mortality Collaboration, Di Angelantonio E, Bhupathiraju Sh N, Wormser D, Gao P, et al. Body-mass index and all-cause mortality: individual- participant-data meta-analysis of 239 prospective studies in four continents. Lancet 2016;388:776-786. https://doi.org/10.1016/s0140-6736(16)30175-1
  • Rucker D., Padwal R., Li S. et al. Long term pharmacotherapy for obesity and overweight updated meta-analysis. British Medical Journal 2007; 335: 1194-1199.
  • Avenell A., Broom J., Brown T. et al. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess 2004, May;8(21):iii-iv,1-182. https://doi.org/10.3310/hta8210
  • Biddle SJH, Bengoechea García E, Pedisic Z, et al. Screen Time, Other Sedentary Behaviours, and Obesity Risk in Adults: A Review of Reviews. Curr Obes Rep. 2017;6(2):134-147. https://doi.org/10.1007/s13679-017-0256-9
  • Heymsfield SB, Wadden TA. Mechanisms, Pathophysiology, and Management of Obesity. Longo DL, ed. N Engl J Med. 2017;376(3):254-266. https://doi.org/10.1056/NEJMra1514009
  • Guh DP, Zhang W, Bansback N, et al. The incidence of comorbidities related to obesity and overweight: A systematic review and meta-analysis. BMC Public Health. 2009;9:88. https://doi.org/10.1186/1471-2458-9-88
  • Lenz M, Richter T, Mühlhauser I. The Morbidity and Mortality Associated With Overweight and Obesity in Adulthood. Dtsch Aerzteblatt Online. 2009;106:641-648. https://doi.org/10.3238/arztebl.2009.0641
  • Cardoso L, Rodrigues D, Gomes L, Carrilho F. Short- and long-term mortality after bariatric surgery: A systematic review and meta-analysis. Diabetes Obes Metab 2017;19:1223-1232. https://doi.org/10.1111/dom.12922
  • Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA 2003;290:86-97. https://doi.org/10.1001/jama.290.1.86
  • Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE, Lung Health Study Research Group. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 2005;142:233-239. https://doi.org/10.7326/0003-4819-142-4-200502150-00005
  • Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev 2018;5:CD000146. https://doi.org/10.1002/14651858.cd000146.pub5
  • Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2007:CD000031. https://doi.org/10.1002/14651858.cd000031.pub4
  • Cahill K, Lindson-Hawley N, Thomas KH, Fanshawe TR, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2016:CD006103. https://doi.org/10.1002/14651858.cd006103.pub7
  • Lindson N, Chepkin SC, Ye W, Fanshawe TR, Bullen C, Hartmann-Boyce J. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2019;4:CD013308. https://doi.org/10.1002/14651858.cd013308
  • Woolf KJ, Zabad MN, Post JM, McNitt S, Williams GC, Bisognano JD. Effect of nicotine replacement therapy on cardiovascular outcomes after acute coronary syndromes. Am J Cardiol 2012;110:968-970. https://doi.org/10.1016/j.amjcard.2012.05.028
  • Eisenberg MJ, Windle SB, Roy N, Old W, Grondin FR, Bata I, Iskander A, Lauzon C, Srivastava N, Clarke A, Cassavar D, Dion D, Haught H, Mehta SR, Baril JF, Lambert C, Madan M, Abramson BL, Dehghani P, EVITA Investigators. Varenicline for Smoking Cessation in Hospitalized Patients With Acute Coronary Syndrome. Circulation 2016;133:21-30. https://doi.org/10.1161/circulationaha.115.019634
  • Benowitz NL, Pipe A, West R, Hays JT, Tonstad S, McRae T, Lawrence D, St Aubin L, Anthenelli RM. Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers: A Randomized Clinical Trial. JAMA Intern Med 2018;178:622-631. https://doi.org/10.1001/jamainternmed.2018.0397
  • Suissa K, Lariviere J, Eisenberg MJ, Eberg M, Gore GC, Grad R, Joseph L, Reynier PM, Filion KB. Efficacy and Safety of Smoking Cessation Interventions in Patients With Cardiovascular Disease: A Network Meta-Analysis of Randomized Controlled Trials. Circ Cardiovasc Qual Outcomes 2017;10:e002458. https://doi.org/10.1161/circoutcomes.115.002458
  • Hu Y, Zong G, Liu G, Wang M, Rosner B, Pan A, Willett WC, Manson JE, Hu FB, Sun Q. Smoking Cessation, Weight Change, Type 2 Diabetes, and Mortality. N Engl J Med 2018;379:623-632. https://doi.org/10.1056/nejmoa1803626
  • Wood AM, Kaptoge S, Butterworth AS, Willeit P, Warnakula S, Bolton T, Paige E, et al. Emerging Risk Factors Collaboration/EPIC-CVD/UK Biobank Alcohol Study Group. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet 2018;391:1513-1523. https://doi.org/10.1016/s0140-6736(18)30134-x
  • Millwood IY, Walters RG, Mei XW, Guo Y, Yang L, Bian Z, Bennett DA, Chen Y, Dong C, Hu R, Zhou G, Yu B, Jia W, Parish S, Clarke R, Davey Smith G, Collins R, Holmes MV, Li L, Peto R, Chen Z, China Kadoorie Biobank Collaborative Group. Conventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in China. Lancet 2019;393:1831-1842. https://doi.org/10.1016/S0140-6736(18)31772-0
  • Holmes MV, Dale CE, Zuccolo L, Silverwood RJ, Guo Y, Ye Z, Prieto-Merino D, Dehghan A, Trompet S, Wong A, Cavadino A, Drogan D, et al. InterAct Consortium. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ 2014;349:g4164. https://doi.org/10.1136/bmj.g4164
  • Albus C, Waller C, Fritzsche K, Gunold H, Haass M, Hamann B, Kindermann I, Kollner V, Leithauser B, Marx N, Meesmann M, Michal M, Ronel J, Scherer M, Schrader V, Schwaab B, Weber CS, Herrmann-Lingen C. Significance of psycho-social factors in cardiology: update 2018: Position paper of the German Cardiac Society. Clin Res Cardiol 2019;108:1175-1196. https://doi.org/10.1007/s00392-019-01488-w
  • Vaccarino V, Badimon L, Bremner JD, Cenko E, Cubedo J, Dorobantu M, Duncker DJ, Koller A, Manfrini O, Milicic D, Padro T, Pries AR, Quyyumi AA, Tousoulis D, Trifunovic D, Vasiljevic Z, de Wit C, Bugiardini R, ESC Scientific Document Group Reviewers. Depression and coronary heart disease: 2018 position paper of the ESC working group on coronary pathophysiology and microcirculation. Eur Heart J 2020;41:1687-1696. https://doi.org/10.1093/eurheartj/ehy913
  • Petersen BD, Stenager E, Mogensen CB, Erlangsen A. The association between heart diseases and suicide: a nationwide cohort study. J Intern Med 2020;287:558-568. https://doi.org/10.1111/joim.13025
  • Albert MA, Glynn RJ, Buring J, Ridker PM. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events. Circulation 2006;114:2619-2626. https://doi.org/10.1161/circulationaha.106.660043
  • Alter DA, Franklin B, Ko DT, Austin PC, Lee DS, Oh PI, Stukel TA, Tu JV. Socioeconomicstatus, functional recovery, and long-term mortality among patients surviving acute myocardial infarction. PLoS One 2013;8(6):e65130. https://doi.org/10.1371/journal.pone.0065130
  • Berntson J, Patel JS, Stewart JC. Number of recent stressful life events and incident cardiovascular disease: Moderation by lifetime depressive disorder. J Psychosom Res 2017; 99: 149-154. https://doi.org/10.1016/j.jpsychores.2017.06.008. Epub 2017 Jun 12.
  • Pogosova N, Saner H, Pedersen SS, Cupples ME, McGee H, Hofer S, Doyle F, Schmid JP, von Kanel R. Psychosocial aspects in cardiac rehabilitation: from theoryto practice. A position paper from the Cardiac Rehabilitation Section of the EuropeanAssociation of Cardiovascular Prevention and Rehabilitation of the EuropeanSociety of Cardiology. Eur J Prev Cardiol 2015;22:1290-1306. https://doi.org/10.1177/2047487314543075
Еще
Статья научная